Zandu Pharmaceuticals manufactures pharmaceutical preparations. The company specialises in ayurvedic products such as Ghritas, Churna and medicinal oils. The products of the company are sold under the brand name 'Zandu'.
Ackruti City (ACL, formerly known as Akruti Nirman) is a real estate company involved in the development, sale and lease of commercial, residential, retail and industrial properties. ACL has been primarily a Mumbai-centric developer and has been a ma... More
ZANDU REALTY | HUBTOWN | ZANDU REALTY/ HUBTOWN |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 24.2 | -2.9 | - | View Chart |
P/BV | x | 0.7 | 0.1 | 831.7% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ZANDU REALTY Mar-14 |
HUBTOWN Mar-19 |
ZANDU REALTY/ HUBTOWN |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,269 | 81 | 1,570.5% | |
Low | Rs | 789 | 31 | 2,578.4% | |
Sales per share (Unadj.) | Rs | 358.5 | 64.7 | 553.9% | |
Earnings per share (Unadj.) | Rs | 474.4 | -1.6 | -29,197.2% | |
Cash flow per share (Unadj.) | Rs | 474.4 | -1.2 | -39,805.2% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Dividend yield (eoy) | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 2,630.2 | 220.3 | 1,194.1% | |
Shares outstanding (eoy) | m | 0.81 | 72.74 | 1.1% | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 2.9 | 0.9 | 333.5% | |
Avg P/E ratio | x | 2.2 | -34.3 | -6.3% | |
P/CF ratio (eoy) | x | 2.2 | -46.7 | -4.6% | |
Price / Book Value ratio | x | 0.4 | 0.3 | 154.7% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 833 | 4,052 | 20.6% | |
No. of employees | `000 | NA | 0.2 | 0.0% | |
Total wages/salary | Rs m | 0 | 237 | 0.0% | |
Avg. sales/employee | Rs Th | NM | 20,292.2 | - | |
Avg. wages/employee | Rs Th | NM | 1,021.6 | - | |
Avg. net profit/employee | Rs Th | NM | -509.5 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 290 | 4,708 | 6.2% | |
Other income | Rs m | 274 | 781 | 35.1% | |
Total revenues | Rs m | 565 | 5,489 | 10.3% | |
Gross profit | Rs m | 225 | 1,431 | 15.7% | |
Depreciation | Rs m | 0 | 32 | 0.0% | |
Interest | Rs m | 3 | 2,183 | 0.2% | |
Profit before tax | Rs m | 496 | -3 | -15,983.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 111 | 115 | 96.6% | |
Profit after tax | Rs m | 384 | -118 | -325.1% | |
Gross profit margin | % | 77.3 | 30.4 | 254.4% | |
Effective tax rate | % | 22.4 | -3,712.9 | -0.6% | |
Net profit margin | % | 132.3 | -2.5 | -5,270.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 1,439 | 27,805 | 5.2% | |
Current liabilities | Rs m | 560 | 26,429 | 2.1% | |
Net working cap to sales | % | 302.5 | 29.2 | 1,035.0% | |
Current ratio | x | 2.6 | 1.1 | 244.1% | |
Inventory Days | Days | 1,310 | 1,146 | 114.3% | |
Debtors Days | Days | 0 | 244 | 0.0% | |
Net fixed assets | Rs m | 0 | 1,020 | 0.0% | |
Share capital | Rs m | 81 | 727 | 11.1% | |
"Free" reserves | Rs m | 1,032 | 15,295 | 6.7% | |
Net worth | Rs m | 2,131 | 16,023 | 13.3% | |
Long term debt | Rs m | 0 | 2,634 | 0.0% | |
Total assets | Rs m | 2,691 | 47,259 | 5.7% | |
Interest coverage | x | 146.7 | 1.0 | 14,694.4% | |
Debt to equity ratio | x | 0 | 0.2 | 0.0% | |
Sales to assets ratio | x | 0.1 | 0.1 | 108.3% | |
Return on assets | % | 14.4 | 4.4 | 329.7% | |
Return on equity | % | 18.0 | -0.7 | -2,445.1% | |
Return on capital | % | 23.4 | 11.7 | 200.4% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 12 | 0.0% | |
Net fx | Rs m | 0 | -12 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 656 | 764 | 85.9% | |
From Investments | Rs m | -627 | 1,514 | -41.4% | |
From Financial Activity | Rs m | NA | -2,187 | 0.0% | |
Net Cashflow | Rs m | 29 | 91 | 31.7% |
Indian Promoters | % | 35.5 | 74.6 | 47.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.3 | 0.1 | 300.0% | |
FIIs | % | 0.0 | 0.5 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 64.2 | 24.8 | 258.9% | |
Shareholders | 27,223 | 22,906 | 118.8% | ||
Pledged promoter(s) holding | % | 0.0 | 90.0 | - |
Compare ZANDU REALTY With: IVRCL ARSS INFRASTRUCTURE MARATHON NEXTGEN MAHINDRA LIFESPACE DS KULKARNI
The market scaled new life-time highs this week but it was the bears who took control. The benchmark indices, Sensex and Nifty ended mostly flat for the week but the momentum was in favour of the bears.
Should you apply for the IPO of Mindspace Business Parks REIT?
For the quarter ended March 2019, HUBTOWN LTD has posted a net profit of Rs 94 m (up 60.4% YoY). Sales on the other hand came in at Rs 276 m (down 65.1% YoY). Read on for a complete analysis of HUBTOWN LTD's quarterly results.
For the quarter ended December 2018, HUBTOWN LTD has posted a net profit of Rs 9 m (down 84.3% YoY). Sales on the other hand came in at Rs 532 m (down 20.7% YoY). Read on for a complete analysis of HUBTOWN LTD's quarterly results.
Should you apply for the IPO of Mindspace Business Parks REIT?
For the quarter ended March 2019, HUBTOWN LTD has posted a net profit of Rs 94 m (up 60.4% YoY). Sales on the other hand came in at Rs 276 m (down 65.1% YoY). Read on for a complete analysis of HUBTOWN LTD's quarterly results.
More Views on NewsWere you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Our ace stock picker is ready to capitalise on a big growth opportunity.
The pandemic failed to thwart Richa's investing success formula for 2020.
More